Evidence map›Paper›PMID 41087568›Full record

ArticleScientific reports2025

Signaling pathways contributing to the transcriptional response to alkalinization in Komagataella phaffii: role of the transcription factors Crz1 and Rim101.

Marcel Albacar, Antonio Casamayor, Abdelghani Zekhnini, Alexander Schmidt, Asier González, Joaquín Ariño

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcel AlbacarInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain.
Antonio CasamayorInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain.
Abdelghani ZekhniniInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain.
Alexander SchmidtBiozentrum, University of Basel, Spitalstrasse 41, 4056, Basel, Switzerland.
Asier GonzálezInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain.
Joaquín AriñoInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain. joaquin.arino@uab.cat.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2023 PROD 00006Ministerio de Ciencia, Innovación y Universidades PID2023-150535OB-I00
6 · The paper itself

Abstract

Promoters able to respond to moderate alkalinization in the industrially relevant yeast Komagataella phaffii have been proposed as a tool for the design of novel methanol-free platforms for heterologous protein expression. However, the molecular bases of such response are unknown. We identify here the transcription factors Crz1 and Rim101 in K. phaffii and use CRISPR/Cas9 techniques to create single and double mutant strains. While crz1 cells are strongly sensitive to Ca

Indexed as

Fungal ProteinsSaccharomycetalesSignal TransductionTranscription FactorsTranscription, GeneticCalciumGene Expression Regulation, FungalHydrogen-Ion ConcentrationCalciumFungal ProteinsTranscription FactorsAlkaline responseKomagataella phaffiiTranscriptional regulationTranscription factors

Identifiers

PMID41087568
PMCPMC12521412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.